• SENSEX
    NIFTY 50
Healthcare

Glenmark shares down 7%; market gets realistic about Fabiflu impact on earnings

Updated : June 23, 2020 03:47 PM IST

Glenmark Pharma shares were down over 7 percent during Tuesday's trading session.
Analysts were surprised at Monday's rally and said that the potential earnings from the sale of Fabiflu did not warrant such a big gain in the stock price.
Glenmark shares down 7%; market gets realistic about Fabiflu impact on earnings

You May Also Like

Live TV

recommended for you

Advertisement